BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6715123)

  • 1. Effects of L-carnitine on adriamycin-induced cardiomyopathy in rabbit.
    Paterna S; Furitano G; Scaffidi L; Barbarino C; Campisi D; Parisi G; Carreca I
    Int J Tissue React; 1984; 6(1):91-5. PubMed ID: 6715123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
    Strauss M; Porras N
    Invest Clin; 2007 Mar; 48(1):33-43. PubMed ID: 17432542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection from adriamycin-induced cardiomyopathy in rats.
    Shug AL
    Z Kardiol; 1987; 76 Suppl 5():46-52. PubMed ID: 3433883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine protection against adriamycin-induced cardiomyopathy in rats.
    McFalls EO; Paulson DJ; Gilbert EF; Shug AL
    Life Sci; 1986 Feb; 38(6):497-505. PubMed ID: 3945174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of carnitine to prevent adriamycin cardiomyopathy.
    Goldsmith MA; Suzuki Y; Ohnuma T; Holland JF
    Cancer Treat Rep; 1979 Apr; 63(4):558-60. PubMed ID: 445512
    [No Abstract]   [Full Text] [Related]  

  • 6. Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy.
    Sayed-Ahmed MM; Salman TM; Gaballah HE; Abou El-Naga SA; Nicolai R; Calvani M
    Pharmacol Res; 2001 Jun; 43(6):513-20. PubMed ID: 11419959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits.
    Dimitrov NV; Hay MB; Siew S; Hudler DA; Charamella LJ; Ullrey DE
    Am J Pathol; 1987 Feb; 126(2):376-83. PubMed ID: 3826299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine promotes heat shock protein synthesis in adriamycin-induced cardiomyopathy in a neonatal rat experimental model.
    Strauss M; Anselmi G; Hermoso T; Tejero F
    J Mol Cell Cardiol; 1998 Nov; 30(11):2319-25. PubMed ID: 9925368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy.
    Lebrecht D; Kirschner J; Geist A; Haberstroh J; Walker UA
    Cardiovasc Pathol; 2010; 19(5):e167-74. PubMed ID: 19747854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
    Jaenke RS
    Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of L-carnitine on cardiac metabolic damage induced by doxorubicin in vitro.
    Neri B; Cini-Neri G; Bartalucci S; Bandinelli M
    Anticancer Res; 1986; 6(4):659-62. PubMed ID: 3752946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diasteroisomer.
    Maccari F; Ramacci MT
    Biomedicine; 1981 May; 35(2):65-7. PubMed ID: 7260239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model.
    Xiang P; Deng HY; Li K; Huang GY; Chen Y; Tu L; Ng PC; Pong NH; Zhao H; Zhang L; Sung RY
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):343-9. PubMed ID: 18379782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin-induced cardiomyopathy. A rat model.
    Czarnecki A; Hinek A; Sołtysiak-Pawluczuk D
    Pol J Pharmacol Pharm; 1986; 38(2):171-7. PubMed ID: 3748888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice.
    Yen HC; Oberley TD; Gairola CG; Szweda LI; St Clair DK
    Arch Biochem Biophys; 1999 Feb; 362(1):59-66. PubMed ID: 9917329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential long-term subcellular responses in heart and liver to adriamycin stress. Exogenous L-carnitine cardiac and hepatic protection.
    Zeidán Q; Strauss M; Porras N; Anselmi G
    J Submicrosc Cytol Pathol; 2002 Jul; 34(3):315-21. PubMed ID: 12408365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vivo animal model to study chronic adriamycin cardiotoxicity: a P-31 nuclear magnetic resonance spectroscopy investigation.
    Thompson RT; Marsh GD; Butland T; Sprague C; Sanford SE; Peemoeller H; Driedger AA; Inch WR
    In Vivo; 1991; 5(1):13-6. PubMed ID: 1932618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
    Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emetine-induced cardiomyopathy in rabbits.
    Khan MY; Haider B; Thind IS
    J Submicrosc Cytol; 1983 Apr; 15(2):495-507. PubMed ID: 6133959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute adriamycin cardiotoxicity: morphologic alterations in isolated perfused rabbit heart.
    Taylor AL; Bulkley BH
    Lab Invest; 1982 Nov; 47(5):459-64. PubMed ID: 7132289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.